Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,787,835 papers from all fields of science
Search
Sign In
Create Free Account
PHENYLALANINE,DL-
Known as:
dl phenylalanine
, DL-Phenylalanine
, PHENYLALANINE, DL-
Expand
A racemic mixture of phenylalanine, an aromatic amino acid with antidepressant, analgesic and appetite suppressant properties. The antidepressant…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Phenylalanine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Synthesis of a novel category of pseudo-peptides using an Ugi three-component reaction of levulinic acid as bifunctional substrate, amines, and amino acid-based isocyanides
M. Khalesi
,
A. Ziyaei Halimehjani
,
J. Martens
Beilstein Journal of Organic Chemistry
2019
Corpus ID: 96442321
The synthesis of a novel category of pseudo-peptides via intramolecular Ugi reaction of levulinic acid (4-oxopentanoic acid…
Expand
2009
2009
Enantioseparation of underivatised amino acids by ligand exchange capillary electrophoresis in a counter-electroosmotic mode
Abderrahim Aït Adoubel
,
C. Morin
,
N. Mofaddel
,
G. Dupas
,
P. Desbène
Analytical and Bioanalytical Chemistry
2009
Corpus ID: 21169531
Enantiomer separations of underivatised amino acids were carried out by using ligand exchange capillary electrophoresis (LECE…
Expand
2001
2001
Ultrafiltration membrane reactors for enzymatic resolution of amino acids: design model and optimization.
A. Bódalo
,
J. L. Gomez
,
E. Gómez
,
J. Bastida
,
M. Máximo
,
M. C. Montiel
Enzyme and Microbial Technology
2001
Corpus ID: 37644038
1978
1978
[DL-phenylalanine as an antidepressant. Open study (author's transl)].
H. Beckmann
,
E. Ludolph
Arzneimittel-Forschung
1978
Corpus ID: 41956841
In an open study dl-phenylalanine in doses from 75--200 mg/day was administered to 20 depressed patients for 20 days. At the end…
Expand
1976
1976
Specificity in enzyme inhibition. 3. Synthesis of 5-substituted 2,2-dimethyl-4-imidazolidinones as inhibitors of tyrosine decarboxylase and histidine decarboxylase.
E. Smissman
,
R. Inloes
,
S. El-Antably
,
P. J. Shaffer
Journal of Medicinal Chemistry
1976
Corpus ID: 25662537
2,2-Dimethyl-4-imidazolidinone derivatives of the alpha-amino acids DL-phenylglycine (1), DL-phenylalanine (2), L-tyrosine (3), L…
Expand
Highly Cited
1973
Highly Cited
1973
The structure of chymostatin, a chymotrypsin inhibitor.
K. Tatsuta
,
N. Mikami
,
K. Fujimoto
,
S. Umezawa
,
H. Umezawa
Journal of antibiotics (Tokyo. )
1973
Corpus ID: 19227787
Chymostatin, a chymotrypsin inhibitor, was shown to be a mixture of components A, B and C. The structure of component A as…
Expand
1973
1973
Polymerization of DL‐phenylalanine NCA initiated by copolymer of sarcosine and DL‐phenylalanine
Y. Imanishi
,
T. Sugihara
,
T. Higashimura
Biopolymers
1973
Corpus ID: 36877586
Polymerizations of DL‐phenylalanine NCA by block copolymers of sarcosine and DL‐phenylalanine, designated by (Phe)m(Sar)n and…
Expand
1966
1966
Studies on the activation of plasminogen. 3. Insoluble derivatives of the proactivator and the activator.
S. Rimon
,
Y. Stupp
,
A. Rimon
Canadian Journal of Biochemistry
1966
Corpus ID: 11416661
An insoluble derivative of plasminogen was prepared by coupling it to a diazotized copolymer of p-amino-DL-phenylalanine and L…
Expand
1962
1962
Preparation and characterization of polytyrosyl trypsin.
A. Glazer
,
A. Bar-Eli
,
E. Katchalski
Journal of Biological Chemistry
1962
Corpus ID: 2045078
Highly Cited
1960
Highly Cited
1960
Actions of the Decarboxylase Inhibitor, α-Methyl-3,4-dihydroxyphenylalanine, in the Dog
L. Goldberg
,
F. Dacosta
,
M. Ozaki
Nature
1960
Corpus ID: 4291499
Alpha-methyl-3,4-dihydroxy-DL-pheny]alanme was shown by Sourkes1to be a potent inhibitor of the decarboxylation of 3,4…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE